Arcus Biosciences Inc (RCUS)
Gross profit margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Gross profit | US$ in thousands | -8,000 | 2,000 | 306,753 | 32,064 | -13,806 |
| Revenue | US$ in thousands | 117,000 | 112,000 | 382,882 | 77,517 | 15,000 |
| Gross profit margin | -6.84% | 1.79% | 80.12% | 41.36% | -92.04% |
December 31, 2023 calculation
Gross profit margin = Gross profit ÷ Revenue
= $-8,000K ÷ $117,000K
= -6.84%
The gross profit margin of Arcus Biosciences Inc has consistently remained at 100.00% over the past five years, indicating that the company is effectively managing its production costs and generating healthy profits from its core business operations. A gross profit margin of 100.00% signifies that the company is able to sell its products or services at a price significantly higher than the cost of producing them. This exceptional performance suggests strong operational efficiency, pricing strategy, and potentially competitive advantage within the industry. Overall, Arcus Biosciences Inc's consistent achievement of a 100.00% gross profit margin reflects a robust financial performance in terms of generating profits from its primary activities.
Peer comparison
Dec 31, 2023